Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: The Odense study

Neurology

Volumn 52, Issue 1, 1999, Pages 85-90

  Andersen, K ^a   Nielsen, H ^a   Lolk, A ^a   Andersen, J ^a   Becker, I ^a   Kragh Sorensen P ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DENMARK; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0032899939     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.85     Document Type: Article

References (43)

1. Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962;86:257-260.
2. Kay DW. Psychiatry of old age: the epidemiology of dementia: a review of recent work. Rev Clin Geron 1991;1:55-66.
3. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667-1674.
4. van Duijn CM. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry 1996;60:478-488.
5. Andersen K, LoLk A, Nielsen H, Andersen J, Olsen C, KraghSφrensen P. Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand 1997;96:82-87.
6. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
7. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment Dis 1976;163:307-317.
8. Reitan R. Validity of Trail Making Test as an indicator of brain damage. Percept Mot Skills 1958;8:271-276.
9. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Services, 1973.
10. Nielsen H, LoLk A, Kragh-Sørensen P. Normative data for eight neuropsychological tests gathered from a random sample of Danes aged 64 to 83 years. Nord Psyk 1995;47:241-255.
11. Benton A. Der Benton Test, Heft 1. Bern, Switzerland: Verlag Hans Huber, 1961.
12. Warrington EK. Deficient recognition memory in organic amnesia. Cortex 1974;10:289-291.
13. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
14. De Renzi E, Faglioni P. Normative data and screening power of a shortened version of the Token Test. Cortex 1978;14: 41-49.
15. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull 1988;24:637-639.
16. Morris JC, McKeel DJ, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41: 469-478.
17. Ganguli M, Ratcliff G, Huff FJ, et al. Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology 1991;10:42-52.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, third edition, revised. Washington, DC: American Psychiatric Association, 1987.
20. Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L. CAMCOG: a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 1995;34:529-541.
21. Lindeboom J, Ter HR, Hooyer C, Dinkgreve M, Jonker C. Some psychometric properties of the CAMCOG. Psychol Med 1993;23:213-219.
22. Jorm A. A method for measuring dementia as a continuum in community surveys. In: Huppert F, Brayne C, O'Connor D, eds. Dementia and normal aging. Cambridge, UK: Cambridge University Press, 1994:244-253.
23. Nelson HE, McKenna P. The use of current reading ability in the assessment of dementia. Br J Soc Clin Psychol 1975;14: 259-267.
24. Letenneur L, Commenges D, Dartigues JF, Barberger GP. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 1994;23:1256-1261.
25. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
26. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43:515-519.
27. Paykel ES, Brayne C, Huppert FA, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325-332.
28. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-1168.
29. Brayne C, Gill C, Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br J Psychiatry 1995;167: 255-262.
30. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education: The Rotterdam study. BMJ 1995;310:970-973.
31. Juva K, Sulkava R, Erkinjuntti T, Valvanne J, Tilvis R. Prevalence of dementia in the city of Helsinki. Acta Neurol Scand 1993;87:106-110.
32. Fratiglioni L, Forsell Y, Aguero TH, Winblad B. Severity of dementia and institutionalization in the elderly: prevalence data from an urban area in Sweden. Neuroepidemiology 1994; 13:79-88.
33. Wernicke TF, Reischies FM. Prevalence of dementia in old age: clinical diagnoses in subjects aged 95 years and older. Neurology 1994;44:250-253.
34. Aevarsson O, Skoog I. Dementia disorders in a birth cohort followed from 85 to 88: the influence of mortality, refusal rate, and diagnostic change on prevalence. Int Psychogeriatr 1997; 9:11-23.
35. Demente i Vejle Amt. Kvalitet, status og indsats. Oplæg. Vejle, Denmark: Vejle Amt, 1996:29.
36. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
37. Skoog I, Lernfelt B, Landahl S, et al. Fifteen-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
38. Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997;45:321-328.
39. O'Connor DW, Pollitt PA, Jones BJ, Hyde JB, Fellowes JL, Miller ND. Continued clinical validation of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 1991; 83:41-45.
40. Hendrie HC, Hall KS, Brittain HM, et al. The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. J Am Geriatr Soc 1988;36:402-408.
41. Unverzagt FW, Hui SL, Farlow MR, Hall KS, Hendrie HC. Cognitive decline and education in mild dementia. Neurology 1998;50:181-185.
42. Copeland JR, Davidson IA, Dewey ME, et al. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 1992;161:230-239.
43. Boothby H, Blizard R, Livingston G, Mann AH. The Gospel Oak Study stage III: the incidence of dementia. Psychol Med 1994;24:89-95.